Overview

Donor Iron Deficiency Study - Red Blood Cells From Iron-deficient Donors: Recovery and Storage Quality

Status:
Enrolling by invitation

Trial end date:
2021-04-01

Target enrollment:

Participant gender:

Summary

Primary Hypothesis - The 24-hour post-transfusion RBC recovery of units obtained from donors exhibiting iron-deficient erythropoiesis will not meet FDA standards for clinical use. - The 24-hour post-transfusion RBC recovery of units obtained after intravenous iron repletion will improve significantly and will meet FDA standards for clinical use.

Phase:

N/A

Details

Lead Sponsor:

Columbia University

Collaborators:

National Heart, Lung, and Blood Institute (NHLBI)
New York Blood Center

Treatments:

Dextrans
Iron
Iron-Dextran Complex